Clinical Trial Update: A Long-Term Extension Trial From of SPM 962 in Advanced Parkinson's Disease Patients [Phase 3]

View source ↗

Summary

This update presents long-term extension trial results for SPM 962 in advanced Parkinson's disease from a Phase 3 program, focusing on extended safety and toler…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• SPM 962

Snippet

Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Parkinson's Disease | Phase 3 | Status: COMPLETED | Results posted: 2014-03-19